Merck | MRK - Assets


Merck reported EUR52.69B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Adidas EUR 21.06B 610M Jun/2026
Adyen EUR 14.72B 2.47B Jun/2026
Akzo Nobel EUR 16.02B 114M Sep/2026
Alcon AG USD 31.1B 521M Jun/2026
Amadeus IT EUR 11.76B 332.2M Jun/2026
Amarin USD 634.08M 9.72M Sep/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 79.94B 3.92B Sep/2026
Bayer EUR 107.29B 659M Jun/2026
Beiersdorf EUR 13.32B 560M Jun/2026
Covestro EUR 13.47B 245M Dec/2025
Danone EUR 48.62B 3.55B Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.29B 174.35M Jun/2026
Genmab DKK 12.52B 139M Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Henkel EUR 36.5B 3.96B Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Infineon EUR 31.66B 54M Jun/2026
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Linde USD 86.32B 502M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
UCB EUR 18.16B 971M Dec/2025